Alzheimer's: What We Know and What We Don't
What We Know and Don t Know About Alzheimer' s Disease
Research has delivered only limited insights into causes and treatments
Getty Images Genes, lifestyle and age are some of the factors known to play a role in Alzheimer's Disease, but more study is needed. Here s what we know
The risk factor
Age is the greatest risk factor for . For most, symptoms first appear after age 65, though brain-imaging scans show that the buildup of specific types of proteins related to Alzheimer's can start wreckage long before visible symptoms emerge. Some of the genes linked to Alzheimer s
One is APOE, which has several forms. reduces your risk of Alzheimer’s, while another, APOE e4, increases your risk. If you receive a copy of APOE e4 from each of your parents, you’ll have the greatest odds of getting Alzheimer’s. How you live matters
Researchers have determined that nutritious food, exercise, sleep, socializing and other positive are good preventive medicine for Alzheimer’s. One study showed that life changes can reduce your chance of developing Alzheimer’s by 35 percent. Who you are matters
Socioeconomic factors, including education, income and even where you live, play a role in whether Alzheimer’s takes hold. Race matters, too: African Americans are twice as likely to develop Alzheimer’s as Caucasians; Hispanics are 1.5 times more likely. But we don t know
What causes the disease
Scientists have yet to learn what triggers the early deposit of abnormal proteins in the brain or how it damages brain neurons. It’s also unknown why a small percentage of people who have plaque buildup don’t end up getting Alzheimer’s. How these genes work
Researchers have yet to figure out the complex genetic processes that are behind Alzheimer’s. Scientists only know that the disease is likely the result of not just one gene but of dozens of genes — and of the complex interactions that occur among them. A medicine that works
There are no drugs available to cure or slow down Alzheimer's, though some may briefly help with its symptoms. Fully 99 percent of clinical trials of Alzheimer’s drugs fail, and some major pharmaceutical companies have stopped trying to develop this class of drugs. What other factors might matter
More study is needed to determine if social factors are causal or if they somehow help build up resilience to the disease through “cognitive reserve,” a sort of stockpile of brain strength, says Jennifer Manly at Columbia University in New York. More on Brain Health
Cancel You are leaving AARP.org and going to the website of our trusted provider. The provider’s terms, conditions and policies apply. Please return to AARP.org to learn more about other benefits. Your email address is now confirmed. You'll start receiving the latest news, benefits, events, and programs related to AARP's mission to empower people to choose how they live as they age. You can also by updating your account at anytime. You will be asked to register or log in. Cancel Offer Details Disclosures
Close In the next 24 hours, you will receive an email to confirm your subscription to receive emails related to AARP volunteering. Once you confirm that subscription, you will regularly receive communications related to AARP volunteering. In the meantime, please feel free to search for ways to make a difference in your community at Javascript must be enabled to use this site. Please enable Javascript in your browser and try again.